Story of my life. The ups & downs are a pain in the ass!
seen from Japan

seen from Türkiye
seen from China
seen from Ireland
seen from Türkiye
seen from Türkiye
seen from United States

seen from Türkiye

seen from Türkiye
seen from Türkiye
seen from Türkiye
seen from Guatemala
seen from Malaysia

seen from Japan

seen from Indonesia

seen from United States
seen from United States
seen from Russia
seen from United States
seen from United States
Story of my life. The ups & downs are a pain in the ass!
Posted @lupiechiconthego 1. Define your goal 2. Believe in your goal 3. Focus on your goal 4. Accomplish your goal #goals #truth #lupusliving #autoimmunediseases #awareness #livelife #future #LupieChiconthego #lovelife via @riplapp Please Donate towards Zuriel Gibson Fashion Show for Lupus today>>> http://bit.ly/2I52ueb. God Bless! (at Omaha, Nebraska) https://www.instagram.com/p/BvtwtqNjUzd/?utm_source=ig_tumblr_share&igshid=e8tko7kyayyn
Thank you everyone for reaching out. I know so many of you are wondering what the treatment was @marissafarina was posting about yesterday. Here’s the simplest way I can break it down: I have an #immunedeficiency called #CVID. I don’t have the amount of antibodies/white blood cells to fight off infection & bacteria the way a normal person does. This causes me to constantly get sick, usually with upper respiratory infections, bronchitis & pneumonia. This isn’t a disease, & no one can catch it, I was born with it. A few women in my family have different variations of #autoimmunediseases… I just got a combination of a little bit of everything. Naturally my career as a #fighter and #martialartist has been always affected by my condition. When I ended up in the hospital with appendicitis after my last #fight over a month ago, they sent in an immunologist (immune system specialist) when they saw how low my levels were in my blood work. The doctor sat me down, & told me it was time for a treatment I’ve been hesitant about my whole life. I was first told about #IVIG (an antibody drip/blood infusion) when I was 13, & after hearing all the side affects I immediately avoided it. One being once you start the treatment, you’re on it for life. This is when I decided to start eating better, living #holistic & focusing on my overall #health. That worked for a few years, but naturally as I get older, my immune system weakens. In the hospital she said without the treatment, I would be virtually guaranteeing an infection. So with the intervention of my family & wife, I caved & said ok. This picture is from my second IVIG treatment which will now be once a month in my home. It was painful, my whole body was sore & fatigued for the rest of the day. This morning however I do feel much better. I’ve been told this week I’ll feel like my best self, next week I’ll feel normal, but then the following week I’ll feel rundown like I’m getting sick & that’s when we start the process all over again. I don’t know what this means for fighting, but I will say this. I’ll never stop training & teaching.I’ll never stop pursuing my dreams. I just might have to alter them. #thebxb #brittanybrutality
#Repost @crohnsdiseasefighter (@get_repost) ・・・ 👌👌👌..... #crohnsdisease #ulcerativecolitis #microcolitis #inflammatoryboweldisease #keepfighting #invisibleillnessawarness #autoimmunediseases
***Lupus Awareness Month***😷 💊💉 - ⏬ ⏬ ⏬ ⏬ 📳 Turn On Post Notifications - _________________________ - 🔹 🔹 🔹 🔹 - #Lupus #fibromyalgia #LivingWithLUPUSoneDayAtaTime!😇 #SurvivingLUPUS #FindACure4LUPUS #LupusAwareness #LupusTruth #LupusSucks #LupusFlares #LupusFatigue #LupusWarrior #LupusFighter #LupusBattle #LupusBrainfog #MyLupusLife #spoonie #lupie #autoimmunediseases #raynaulds #arthritis #chronicillness #chronicpain #Paingry #spoonieproblems #sick #ill #Discoid #SLE #TRuLUPUSreliefCHRONICLES!📝
Explore the Rheumatoid Factor Latex Agglutination Test Kit market, projected to reach \$2,014 million by 2033 with a 6.5% CAGR. Discover key
The Rheumatoid Factor Latex Agglutination Test Kit market is witnessing steady growth as demand rises for rapid, reliable, and cost-effective autoimmune disease diagnostics. These test kits play a crucial role in the early detection and management of rheumatoid arthritis, helping healthcare providers improve treatment outcomes and patient care.
Key market growth drivers include: ✔ Increasing prevalence of rheumatoid arthritis and autoimmune disorders ✔ Growing adoption of point-of-care diagnostic testing ✔ Rising demand for rapid and affordable diagnostic solutions ✔ Advancements in immunodiagnostic and latex agglutination technologies
Healthcare laboratories and hospitals are increasingly adopting advanced RF test kits due to their quick turnaround time, ease of use, and improved diagnostic efficiency. North America currently leads the market, while Asia-Pacific is emerging rapidly with expanding healthcare infrastructure and diagnostic awareness.
As healthcare systems continue focusing on early disease detection and precision diagnostics, the Rheumatoid Factor Latex Agglutination Test Kit industry is expected to create strong growth opportunities in the coming years.
Read more: TrendVault Research Report
#Healthcare #Diagnostics #AutoimmuneDiseases #RheumatoidArthritis #MedicalDevices #PointOfCareTesting #Biotechnology #HealthcareInnovation #ClinicalDiagnostics #Immunodiagnostics #MedicalResearch #MarketResearch #TrendVaultResearch
𝗜𝗻-𝗗𝗲𝗽𝘁𝗵 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀 𝗼𝗳 𝘁𝗵𝗲 𝗚𝗹𝗼𝗯𝗮𝗹 𝗜𝗺𝗺𝘂𝗻𝗼𝘀𝘂𝗽𝗽𝗿𝗲𝘀𝘀𝗮𝗻𝘁𝘀 𝗠𝗮𝗿𝗸𝗲𝘁: 𝗚𝗿𝗼𝘄𝘁𝗵, 𝗗𝗿𝗶𝘃𝗲𝗿𝘀, 𝗮𝗻𝗱 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀
The global 𝗜𝗺𝗺𝘂𝗻𝗼𝘀𝘂𝗽𝗽𝗿𝗲𝘀𝘀𝗮𝗻𝘁𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 size is predicted to reach 𝗨𝗦𝗗 𝟵𝟴.𝟳𝟬 𝗯𝗶𝗹𝗹𝗶𝗼𝗻 by 2030 with a 𝗖𝗔𝗚𝗥 𝗼𝗳 𝟭𝟱.𝟮% by 2030.
𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗙𝗥𝗘𝗘 𝗦𝗮𝗺𝗽𝗹𝗲
𝗣𝗿𝗶𝗺𝗮𝗿𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 𝗗𝗿𝗶𝘃𝗲𝗿𝘀
Several key factors are propelling this market forward:
Rising Incidence of Autoimmune Disorders: There is a steady global increase in autoimmune diseases, such as rheumatoid arthritis, lupus, and multiple sclerosis, necessitating long-term immunosuppressive therapy.
Growing Number of Organ Transplants: Advances in surgical techniques, better donor matching, and improved post-operative care have led to an increase in organ transplantations globally, which directly drives the lifelong demand for anti-rejection maintenance medicines.
Shift Toward Biologics and Monoclonal Antibodies: The market is experiencing a prominent shift from conventional immunosuppressants to targeted biologic therapies. Monoclonal antibodies are increasingly favored for their precision in modulating specific immune pathways while minimizing broad systemic side effects.
𝗞𝗲𝘆 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀
Novartis
Astellas Pharma
Sanofi
Bristol Myers Squibb.